Mirvetuximab Soravtansine Market Gains Momentum as Targeted Oncology Therapies Expand Worldwide
https://growthmarketreports.co....m/report/mirvetuxima
The global Mirvetuximab Soravtansine market stood at USD 1.64 billion in 2025, driven by rising ovarian cancer incidence and ADC adoption.
إعجاب
علق
شارك
